HECTD2 is associated with susceptibility to mouse and human prion disease
about
The ubiquitin proteasome system in neuropathologyThe proinflammatory role of HECTD2 in innate immunity and experimental lung injuryGenome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNPIdentification of a gene regulatory network associated with prion replication.Genomic and post-genomic analyses of human prion diseasesHECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q.Genetic studies in human prion diseases.The retinoic acid receptor beta (Rarb) region of Mmu14 is associated with prion disease incubation time in mouse.Transcriptional analysis implicates endoplasmic reticulum stress in bovine spongiform encephalopathyEvidence for varied aetiologies regulating the transmission of prion disease: implications for understanding the heritable basis of prion incubation times.Sex effects in mouse prion disease incubation time.Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study.A common BACE1 polymorphism is a risk factor for sporadic Creutzfeldt-Jakob diseaseMolecular pathology of human prion disease.Review: contribution of transgenic models to understanding human prion disease.Sod1 deficiency reduces incubation time in mouse models of prion diseaseChronic wasting disease prions are not transmissible to transgenic mice overexpressing human prion protein.Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entryGenome wide association studies and prion disease.Contrasting genetic architectures in different mouse reference populations used for studying complex traits.Overexpression of the Hspa13 (Stch) gene reduces prion disease incubation time in mice.Prion diseases as transmissible zoonotic diseases.Interaction between misfolded PrP and the ubiquitin-proteasome system in prion-mediated neurodegeneration.Genetics of prion diseasesRegulation of proteasomes in prion disease.In vitro screen of prion disease susceptibility genes using the scrapie cell assay.Misfolding leads the way to unraveling signaling pathways in the pathophysiology of prion diseases.Neurodegenerative Disease Transmission and Transgenesis in Mice.Early Origin and Evolution of the Angelman Syndrome Ubiquitin Ligase Gene Ube3a.A genomic survey of HECT ubiquitin ligases in eukaryotes reveals independent expansions of the HECT system in several lineages.Functional genomics approach for identification of molecular processes underlying neurodegenerative disorders in prion diseases.A Copine family member, Cpne8, is a candidate quantitative trait gene for prion disease incubation time in mouse.Deubiquitinating enzyme VCIP135 dictates the duration of botulinum neurotoxin type A intoxication.What's next for genomics and prion diseases?A polymorphism in the YWHAH gene encoding 14-3-3 eta that is not associated with sporadic Creutzfeldt-Jakob disease (CJD).
P2860
Q24644208-68F7DDE1-C24F-4967-8548-4B8E393A6082Q28383410-6DAB027E-E72B-4B05-84DF-5E6CDA8A3526Q28943533-E8104F1E-55DD-468B-8454-1A35B0B9F90AQ30458186-FCFD1CD4-E1A8-4B6C-A149-E4F9CB026CC5Q33347355-9EC5556C-63F8-41D2-A259-2C44625B3E21Q33503386-218A952E-D3D6-4294-8350-6CCCEE25D5C9Q33627593-4F15075B-04B8-433E-91F9-FE85E349C805Q33769410-043449A2-41FE-47FB-B54B-A600D53E4909Q33769602-0F5B32A5-F3ED-4601-BCAC-670FAB67BA00Q33769832-3386D72D-BC51-4612-BCB2-AEF1E6444CB5Q34103332-39E78902-DE99-45D1-9C4E-311B5AFB1241Q34153674-904A3BC4-6AED-4021-958D-DF22C3D33A6AQ34405864-EB319198-3798-41BB-A076-732888146AC8Q34462913-89837AEC-3E2E-473A-A389-B146A2389D4DQ34474868-FD371C0B-780E-48A5-9924-6C3592A3503DQ34563121-5CBAE39E-4FE2-416C-AD38-C6E72637803AQ34641947-677012A2-4E31-4596-8158-08D33C425821Q35177001-86B49F1E-BCA5-4704-A7A1-022FDA992EE8Q35578768-9006D7A4-E49E-4C24-BE63-67A6132BA780Q35664102-33233771-4598-47BE-9D4B-EBE286AE4446Q36187263-12C90F4C-6582-4449-B500-BD1B131C9FCDQ37105925-2AF95C7A-BEB5-4020-816F-9FD4D1A76A62Q38085466-46370B9E-FA68-4500-9A44-794918C4F48AQ38091816-2DDC4E62-7E91-4011-84F7-579107A9A648Q38211846-6CE6C541-00BD-49B2-8138-49EBDFD2C8B2Q38994453-AA01F3DB-B79B-43F6-8673-0E7BE6E49201Q39015438-5325435F-2978-4A59-8F27-9A97254D8F2FQ39134078-7D0F94AE-931D-49BA-B0F6-4278FEBBBF69Q39191796-AA34AA98-CE60-4394-93EC-1269045CE01DQ39438764-370E929E-088C-4C4F-B724-869E03CD85F9Q39474448-BF3ECB94-5F5C-4E43-BB80-0BBE918FA558Q40013569-1CCFF671-BDB7-43B6-8230-25E508D5AEC5Q40184284-7EE3464E-A902-4BF6-8023-42071D83B240Q42353646-1C1EB4C7-7C38-4F0B-825B-CBEA99F59B74Q49074496-1DBF5B6B-031D-46D7-B588-A3601D50E7C8
P2860
HECTD2 is associated with susceptibility to mouse and human prion disease
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
HECTD2 is associated with susceptibility to mouse and human prion disease
@ast
HECTD2 is associated with susceptibility to mouse and human prion disease
@en
type
label
HECTD2 is associated with susceptibility to mouse and human prion disease
@ast
HECTD2 is associated with susceptibility to mouse and human prion disease
@en
prefLabel
HECTD2 is associated with susceptibility to mouse and human prion disease
@ast
HECTD2 is associated with susceptibility to mouse and human prion disease
@en
P2093
P2860
P1433
P1476
HECTD2 is associated with susceptibility to mouse and human prion disease
@en
P2093
Eleni Molou
Emma G Maytham
Hirva Pota
Holger Hummerich
James Uphill
Jerome Whitfield
John Collinge
Julia Grizenkova
Michael P Alpers
Sarah E Lloyd
P2860
P304
P356
10.1371/JOURNAL.PGEN.1000383
P577
2009-02-13T00:00:00Z